Ruth Oren Hommonai
Chief Executive Officer en INTER GAMMA INVESTMENT COMPANY LTD .
Perfil
Ruth Oren Hommonai is currently the Chief Executive Officer at Inter-Gamma Investment Ltd.
She previously worked as the Director of the Legal Department at Dexcel Pharma Technologies Ltd.
Ms. Oren Hommonai graduated from Tel-Aviv University and holds an MBA from The Interdisciplinary Center Herzliya.
Cargos activos de Ruth Oren Hommonai
| Empresas | Cargo | Inicio |
|---|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Chief Executive Officer | 01/01/2014 |
Antiguos cargos conocidos de Ruth Oren Hommonai.
| Empresas | Cargo | Fin |
|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | General Counsel | - |
Formación de Ruth Oren Hommonai.
| Tel-Aviv University | Graduate Degree |
| The Interdisciplinary Center Herzliya | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INTER GAMMA INVESTMENT COMPANY LTD | Finance |
| Empresas privadas | 1 |
|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Ruth Oren Hommonai
